NHGRI, Smithsonian and NIH Foundation present conversations on genomics, health

WHAT: The National Human Genome Research Institute (NHGRI), the Smithsonian’s National Museum of Natural History (NMNH), and the Foundation for the National Institutes of Health will present a symposium on the future of genomics, health, and the impact of genomics globally.

The symposium will feature conversations with leaders in the field of genomics whose varied and evocative perspectives illuminate genomic advances in the coming decade and aspects of its relevance for global health. The symposium will include an afternoon and an evening session. Both will be open to the public, who must register but will be admitted free of charge.

WHEN AND WHO: Sept. 30, 2014

Afternoon Program

  • 1:30 – 3:00 p.m.
    The Future of Genomics ~ Directions in research, roles for private citizens in genetics testing and research, access to genomic testing, and clinical practices.
    Eric Green, M.D., Ph.D., Director, NHGRI
    Anne Wojcicki, CEO and Co-Founder, 23andMe
    Richard Lifton, M.D., Ph.D., Professor of Genetics and Medicine, Yale University
  • 3:15 – 4:45 p.m.
    Genomics and Global Health ~ Considering genomics and Ebola, and cures and treatments for diseases that affect populations in developing countries.
    Pardis Sabeti, Ph.D., Associate Professor, Harvard University and a Senior Associate Member of the Broad Institute of Harvard and MIT
    Charles Rotimi, Ph.D., Director, Center for Research on Genomics and Global Health, NHGRI

Evening Program

  • 6:45 – 8:45 p.m.
    A Conversation with Carolyn Hax: Ask Me About Health, Genetics, and Dealing with Disease ~ A discussion of questions submitted in advance from registrants.
    Carolyn Hax, Washington Post Advice Columnist
    Barbara Bowles Biesecker, Ph.D., Director, Genetic Counseling Training Program, NHGRI and The Johns Hopkins University
    David Valle, M.D., Professor and Director, Institute of Genetic Medicine, The Johns Hopkins University School of Medicine.

WHERE: NMNH’s Baird Auditorium, ground floor, 10th and Constitution Ave N.W., Washington, D.C.

NOTE: Limited seating is reserved for members of the press. Please contact Raymond MacDougall, or call 301-443-3523. Members of the public must register for both the day and evening at the following website:

The symposium is the culmination of a year-long series of public programs accompanying the NHGRI-NMNH collaboration on the exhibition, Genome: Unlocking Life’s Code. The exhibition has begun a schedule of traveling engagements across North America. To read more about the traveling exhibition, visit:

NHGRI is one of the 27 institutes and centers at the National Institutes of Health. NHGRI conducts genomics research in its own labs in Maryland, as well supports genomics research at institutions across the country.  Additional information about NHGRI can be found at

About the National Institutes of Health (NIH): NIH, the nation’s medical research agency, includes 27 institutes and centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both   common and rare diseases. For more information about NIH and its programs, visit


Raymond MacDougall
301- 443-3523

In the News

Here's what's happening with eMerge:


Read the full press release here. Congratulations to all the sites in the next round of eMERGE! The new clinical sites will be led by: Iftikhar J. Kullo, M.D., at Mayo Clinic, Rochester, Minnesota Dan M. Roden, M.D., at Vanderbilt University Medical Center, Nashville, Tennessee Elizabeth W. Karlson, M.D., at Brigham and Women’s Hospital, Boston Rex […]


The eMERGE Network is excited to share that the MCS NT304, Predictive Utility of Polygenic Risk Scores for Coronary Heart Disease in the eMERGE Network; was published on May 7th to American Journal of Human Genetics.


Two companion RFAs for the PRS Diversity Consortium are now published: Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry – Study Sites (U01 Clinical Trial Not Allowed): Polygenic Risk Score (PRS) Methods and Analysis for Populations of Diverse Ancestry – Coordinating Center (U01 Clinical Trial Not Allowed): The goal […]


Notice to Encourage Eligible NHGRI Awardees to Apply for PA-18-906 “Research Supplements to Promote Diversity in Health-Related Research” PIs of active NHGRI research grants can apply; identify eligible individuals, including those from underrepresented groups, for support and mentorship under the auspices of this supplement opportunity. Supplement can support individuals from the undergraduate to the […]